606145-75-9

Basic information

• Product Name: N-(5-chloro-2-cyanophenyl)benzamide
• Synonyms: N-(5-chloro-2-cyanophenyl)benzamide
• CAS NO: 606145-75-9
• Molecular Weight: 256.691
• Mol File: 606145-75-9.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: N-(5-chloro-2-cyanophenyl)benzamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(5-chloro-2-cyanophenyl)benzamide(606145-75-9)
• EPA Substance Registry System: N-(5-chloro-2-cyanophenyl)benzamide(606145-75-9)

Safety Data

• Hazardous Substances Data: 606145-75-9(Hazardous Substances Data)

Upstream product

• 38487-86-4 2-amino-4-chlorobenzonitrile 
• 98-86-2 acetophenone 
• 57039-63-1 6-chloro-2-phenylindole 
• 92424-05-0 Acetophenon-(m-chlor-phenylhydrazon) 
• 14763-20-3 3-chlorophenyl hydrazine 
• 98-88-4 benzoyl chloride 

Downstream Products

• 7012-94-4 7-chloro-5-methyl-2-phenylquinazolin-4(3H)-one 

Relevant articles and documents

Pd-Catalyzed tandem reaction of N-(2-cyanoaryl)benzamides with arylboronic acids: synthesis of quinazolines

The synthesis of 2,4-disubstituted quinazolines by a palladium-catalyzed reaction of arylboronic acids with N-(2-cyanoaryl)benzamides has been developed with moderate to excellent yields. The method shows good functional group tolerance. In particular, ha

6,6-BICYCLIC RING SUBSTITUTED HETEROBICYCLIC PROTEIN KINASE INHIBITORS

Compounds of the formula (I) and pharmaceutically acceptable salts thereof, wherein XI, X2, X3, X4, X5, X6, X7, R1, and Q1 are defined herein, inhibit the IGF-1R enzyme and are useful for the treatment and/or prevention of hyperproliferative diseases such as cancer, inflammation, psoriasis, allergy/asthma, disease and conditions of the immune system, disease and conditions of the central nervous system.